pembrolizumab,toripalimab,nivolumab,ipilimumab,Atezolizumab,durvalumab,Cisplatin,Vinorelbine,Gemcitabine,Docetaxel,Pemetrexed,Carboplatin,Paclitaxel
merck,Roche,BMS,Coherus,Junshi Biosciences,Astrazeneca
['lcsm,(-blcsm)']
acknowledging cross trial comparisons, neoadjuvant &amp; perioperative treatment strategies appear more promising w/ os benefit as compared to adjuvant strategies #asco23 #lcsm 
Thoracic Medical Oncologist, Assistant Professor @MDAndersonNews | Interested in patient education, PROs, personalized care | 🫁#cancer #lcsm | Views are my own